Find the latest pharmaceutical market place for formulations enquiry about Ponatinib on PharmaCompass.com.

turkeypng-1602828403png-1622460951png-1622462103 Flag

Various Finished Dosage Formulations needed in Turkey [ENA11323]

A company that deals in oncology, urology, women's health and rare diseases and offers innovative treatments and ground-breaking genetic technologies is looking for suppliers of Various Finished Dosage Formulations for commercial purpose. The suppliers must support this enquiry with PIC/S, GMP and CoA.
1. Naltrexone Hydrochloride (50 mg) Capsules/ Tablets
2. Nelarabin (250 mg) Ampoules
3. Pegaspargase (3750 IU) Vials
4. Ponatinib (45 mg) Tablets
5. Pralatrexate (20 mg/ ml) Vials
6. Romidepsin (10 mg) Vials

Reply

07 Sep 2021

Various Finished Dosage Formulations needed in Jordan [ENA08350]

Swe Moc Group AB, a distributor company that deals in various pharmaceutical products is looking for suppliers of Various Finished Dosage Formulations. The suppliers must support this enquiry with CEP or FDA. The final market is the Middle East countries. Interested suppliers can contact them via their email: mohamed.abdo@swemoc.com.
1. Ribomustin (100 mg/ 60 ml) Vial. The required quantity is 60 units.
2. Cabozantinib (60 mg) Tablets. The required quantity is 30 tablets in 68 units.
3. Ponatinib (15 mg) Tablets. The required quantity is 30 tablets in 80 units.
4. Upadacitinib (15 mg) Tablets. The required quantity is 28 tablets in 70 units.
5. Erwinase (10,000 units/ vial). The required quantity is 120 units.

Reply

25 Aug 2020